In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Here’s What’s Entering the Public Domain in 2026 If you want to make a dark and twisted Betty Boop slasher film, have at it.